内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2016 ETA/EUGOGO指南：Graves眼病的管理

2016-04-01 欧洲甲状腺协会 Eur Thyroid J. 2016 Mar;5(1):9-26.

Graves眼病甲状腺

近几年有好多关于Graves眼病的RCT研究发布，这些研究结果对Graves眼病患者的影响显著，因此，欧洲甲状腺协会(ETA)联合欧洲Graves' 眼病专家组(EUGOGO)共同发布了Graves眼病的管理指南。指南针对Graves' 的评估和治疗等内容共提出了17条推荐意见。

中文标题：

2016 ETA/EUGOGO指南：Graves眼病的管理

英文标题：

The 2016 European Thyroid Association/European Group on Graves'''' Orbitopathy Guidelines for the Management of Graves'''' Orbitopathy

发布机构：

欧洲甲状腺协会

发布日期：

2016-04-01

简要介绍：

近几年有好多关于Graves眼病的RCT研究发布，这些研究结果对Graves眼病患者的影响显著，因此，欧洲甲状腺协会(ETA)联合欧洲Graves' 眼病专家组(EUGOGO)共同发布了Graves眼病的管理指南。指南针对Graves' 的评估和治疗等内容共提出了17条推荐意见。

相关资料下载：
[AttachmentFileName(sort=100, fileName=2016 ETA/EUGOGO指南：Graves眼病的管理)] GetToolGuiderByIdResponse(projectId=1, id=d748d1c00118e29a, title=2016 ETA/EUGOGO指南：Graves眼病的管理, enTitle=The 2016 European Thyroid Association/European Group on Graves'''' Orbitopathy Guidelines for the Management of Graves'''' Orbitopathy, guiderFrom=Eur Thyroid J. 2016 Mar;5(1):9-26., authorId=null, author=, summary=近几年有好多关于Graves眼病的RCT研究发布，这些研究结果对Graves眼病患者的影响显著，因此，欧洲甲状腺协会(ETA)联合欧洲Graves' 眼病专家组(EUGOGO)共同发布了Graves眼病的管理指南。指南针对Graves' 的评估和治疗等内容共提出了17条推荐意见。, cover=, journalId=null, articlesId=null, associationId=483, associationName=欧洲甲状腺协会, associationIntro=欧洲甲状腺协会（European Thyroid Association ETA)成立于1965年，此后每年定期举行一次国际甲状腺会议，会员资格等级分为荣誉会员、普通会员、初级会员、团体会员、合作会员、高级会员六类，目前有600余名会员。旨在推动甲状腺学（基础和临床）及甲状腺病学的发展。, copyright=0, guiderPublishedTime=Fri Apr 01 08:00:00 CST 2016, originalUrl=, linkOutUrl=, content=<span style="text-indent: 28px;">近几年有好多关于Graves眼病的RCT研究发布，这些研究结果对Graves眼病患者的影响显著，因此，欧洲甲状腺协会(ETA)联合欧洲Graves' 眼病专家组(EUGOGO)共同发布了Graves眼病的管理指南。指南针对Graves' 的评估和治疗等内容共提出了17条推荐意见。</span>, tagList=[TagDto(tagId=26062, tagName=Graves眼病), TagDto(tagId=736, tagName=甲状腺)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=32, categoryName=眼科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=null, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5004, appHits=284, showAppHits=0, pcHits=3616, showPcHits=1896, likes=207, shares=13, comments=3, approvalStatus=1, publishedTime=Fri Apr 01 00:00:00 CST 2016, publishedTimeString=2016-04-01, pcVisible=1, appVisible=1, editorId=null, editor=chenglong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=null, createdTime=Fri Apr 01 00:00:00 CST 2016, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 07:40:18 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 ETA/EUGOGO指南：Graves眼病的管理)])
2016 ETA/EUGOGO指南：Graves眼病的管理
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2113390, encodeId=a44c211339009, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0562596408, createdName=er.ying, createdTime=Tue Feb 07 10:35:55 CST 2023, time=2023-02-07, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1200660, encodeId=739d1200660dc, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Tue Mar 08 20:36:07 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954856, encodeId=7a7f9548567e, content=已看，还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:44:33 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2023-02-07 er.ying 来自辽宁省

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2113390, encodeId=a44c211339009, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0562596408, createdName=er.ying, createdTime=Tue Feb 07 10:35:55 CST 2023, time=2023-02-07, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1200660, encodeId=739d1200660dc, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Tue Mar 08 20:36:07 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954856, encodeId=7a7f9548567e, content=已看，还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:44:33 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2022-03-08 245462683

    不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2113390, encodeId=a44c211339009, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0562596408, createdName=er.ying, createdTime=Tue Feb 07 10:35:55 CST 2023, time=2023-02-07, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1200660, encodeId=739d1200660dc, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Tue Mar 08 20:36:07 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954856, encodeId=7a7f9548567e, content=已看，还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:44:33 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-04-07 ms6000001015893838

    已看，还可以。

    0